Arizona State Retirement System’s ARS Pharmaceuticals SPRY Stock Holding History

Arizona State Retirement System’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$120K	Sell	14,930 -442	-3%	-$4.24K	﹤0.01%	2001
2025 Q4	$179K	Buy	15,372 +2,299	+18%	+$22.4K	﹤0.01%	1941
2025 Q3	$131K	Buy	13,073 +204	+2%	+$2.93K	﹤0.01%	2040
2025 Q2	$225K	Buy	12,869 +1,760	+16%	+$25.4K	﹤0.01%	1861
2025 Q1	$140K	Sell	11,109 -121	-1%	-$1.46K	﹤0.01%	1966
2024 Q4	$118K	Buy	11,230 +70	+0.6%	+$980	﹤0.01%	2061
2024 Q3	$162K	Buy	+11,160	New	+$133K	﹤0.01%	2018
2023 Q4	–	Sell	-10,794	Closed	-$40.8K	–	2191
2023 Q3	$40.8K	Buy	10,794 +188	+2%	+$1.23K	﹤0.01%	2157
2023 Q2	$71.1K	Buy	+10,606	New	+$70.8K	﹤0.01%	2153

Other funds holding SPRY

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Arizona State Retirement System's SPRY Position: Q1 2026 in Review

Arizona State Retirement System reduced its ARS Pharmaceuticals (SPRY) stake by 2.9% in Q1 2026, selling an estimated $4.24K and leaving 14,930 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

Arizona State Retirement System first reported a position in SPRY in Q2 2023 and has held it in 9 quarters since. The position peaked at $225K in Q2 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

Arizona State Retirement System held 14,930 shares of ARS Pharmaceuticals worth $120K as of Q1 2026.
Arizona State Retirement System sold 442 ARS Pharmaceuticals shares in Q1 2026, an estimated $4.24K.
ARS Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #2001 holding.
Arizona State Retirement System first reported a position in ARS Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
Arizona State Retirement System's ARS Pharmaceuticals position peaked at $225K in Q2 2025.
202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.